CG
Charles F. Gilks

Publications (3)

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min
Article scientifique · 2019
The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data
Article scientifique · 2017
Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study
Article scientifique · 2016

Domaines principaux

Sciences de la santé3

Statistiques

Consultations6
Téléchargements0